Cargando…
Exploring human biology with N-of-1 clinical trials
Studies on humans that exploit contemporary data-intensive, high-throughput ‘omic’ assay technologies, such as genomics, transcriptomics, proteomics and metabolomics, have unequivocally revealed that humans differ greatly at the molecular level. These differences, which are compounded by each indivi...
Autores principales: | Schork, N. J., Beaulieu-Jones, B., Liang, W. S., Smalley, S., Goetz, L. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228692/ https://www.ncbi.nlm.nih.gov/pubmed/37255593 http://dx.doi.org/10.1017/pcm.2022.15 |
Ejemplares similares
-
Does Modulation of an Epigenetic Clock Define a Geroprotector?
por: Schork, Nicholas J., et al.
Publicado: (2022) -
Assessing brain and biological aging trajectories associated with Alzheimer’s disease
por: Liang, Winnie S., et al.
Publicado: (2022) -
Power and Design Issues in Crossover-Based N-Of-1 Clinical Trials with Fixed Data Collection Periods
por: Wang, Yanpin, et al.
Publicado: (2019) -
Explorations in human biology
por: Johnson, George Brooks, 1942-
Publicado: (1995) -
Exploration of biological network centralities with CentiBiN
por: Junker, Björn H, et al.
Publicado: (2006)